KDR2-2 suspension eye drops
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KDR2-2 suspension eye drops, covering 2021-08-18 to 2021-08-18. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization [Phase 1, Phase 2]